dapagliflozin / saxagliptin Oral Tablet

RxNorm Status History#

Dose form, RxCUI table
Dose form	RxCUI
Oral Tablet	317541

Ingredient, RxCUI table
Ingredient	RxCUI
dapagliflozin	1488564
saxagliptin	857974

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	dapagliflozin / sAXagliptin Oral Tablet	1	NAMES
RxNorm Name	dapagliflozin / saxagliptin Oral Tablet	1	NAMES
TTY	SCDF	1	ATTRIBUTES
RxCUI	1925497	1	CODES

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Adverse event summaries are temporarily unavailable. Other product information remains available.

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	A10BD	Combinations of oral blood glucose lowering drugs	ATC1-4		dapagliflozin / saxagliptin
ATC	A10BH	Dipeptidyl peptidase 4 (DPP-4) inhibitors	ATC1-4		saxagliptin
ATC	A10BK	Sodium-glucose co-transporter 2 (SGLT2) inhibitors	ATC1-4		dapagliflozin
FDASPL	N0000187059	Sodium-Glucose Cotransporter 2 Inhibitor	EPC	has_epc	dapagliflozin
FDASPL	N0000187058	Sodium-Glucose Transporter 2 Inhibitors	MOA	has_moa	dapagliflozin
MEDRT	D000218	Adamantane	CHEM	has_ingredient	saxagliptin
MEDRT	D001559	Benzhydryl Compounds	CHEM	has_ingredient	dapagliflozin
MEDRT	D004151	Dipeptides	CHEM	has_ingredient	saxagliptin
MEDRT	D005960	Glucosides	CHEM	has_ingredient	dapagliflozin
MEDRT	D003924	Diabetes Mellitus, Type 2	DISEASE	may_treat	dapagliflozin
MEDRT	D003924	Diabetes Mellitus, Type 2	DISEASE	may_treat	saxagliptin
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	saxagliptin
MEDRT	D006333	Heart Failure	DISEASE	may_treat	dapagliflozin
MEDRT	N0000175912	Dipeptidyl Peptidase 4 Inhibitors	MOA	has_moa	saxagliptin
MEDRT	N0000187058	Sodium-Glucose Transporter 2 Inhibitors	MOA	has_moa	dapagliflozin
MEDRT	N0000008644	Decreased Glucagon Secretion	PE	has_pe	saxagliptin
MEDRT	N0000175650	Decreased Sympathetic Activity	PE	has_pe	dapagliflozin
MEDRT	N0000009360	Increased Insulin Secretion	PE	has_pe	saxagliptin
MEDRT	N0000009556	Increased Renal Organic Ion Excretion	PE	has_pe	dapagliflozin
MEDRT	N0000009830	Renal Ion Transport Alteration	PE	has_pe	dapagliflozin

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Qtern	rxnav_allrelated
DF	DF	Oral Tablet	rxnav_allrelated
DFG	DFG	Oral Product	rxnav_allrelated
DFG	DFG	Pill	rxnav_allrelated
IN	IN	dapagliflozin	rxnav_allrelated
IN	IN	saxagliptin	rxnav_allrelated
MIN	MIN	dapagliflozin / saxagliptin	rxnav_allrelated
SBD	SBD	dapagliflozin 10 MG / saxagliptin 5 MG Oral Tablet [Qtern]	rxnav_allrelated
SBD	SBD	dapagliflozin 5 MG / saxagliptin 5 MG Oral Tablet [Qtern]	rxnav_allrelated
SBDC	SBDC	dapagliflozin 10 MG / saxagliptin 5 MG [Qtern]	rxnav_allrelated
SBDC	SBDC	dapagliflozin 5 MG / saxagliptin 5 MG [Qtern]	rxnav_allrelated
SBDF	SBDF	dapagliflozin / saxagliptin Oral Tablet [Qtern]	rxnav_allrelated
SBDG	SBDG	Qtern Oral Product	rxnav_allrelated
SBDG	SBDG	Qtern Pill	rxnav_allrelated
SCD	SCD	dapagliflozin 10 MG / saxagliptin 5 MG Oral Tablet	rxnav_allrelated
SCD	SCD	dapagliflozin 5 MG / saxagliptin 5 MG Oral Tablet	rxnav_allrelated
SCDC	SCDC	dapagliflozin 10 MG	rxnav_allrelated
SCDC	SCDC	dapagliflozin 5 MG	rxnav_allrelated
SCDC	SCDC	saxagliptin 5 MG	rxnav_allrelated
SCDF	SCDF	dapagliflozin / saxagliptin Oral Tablet	rxnav_allrelated
SCDG	SCDG	dapagliflozin / saxagliptin Oral Product	rxnav_allrelated
SCDG	SCDG	dapagliflozin / saxagliptin Pill	rxnav_allrelated

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	GENERAL_CARDINALITY	MULTI
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
CODES	USP	m14128
NAMES	Tallman Synonym	dapagliflozin / sAXagliptin Oral Tablet
SOURCES	Source	United States Pharmacopeia